{
    "id": 28959,
    "fullName": "FEN1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "FEN1 over exp indicates an over expression of the Fen1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2237,
        "geneSymbol": "FEN1",
        "terms": [
            "FEN1",
            "FEN-1",
            "MF1",
            "RAD2"
        ]
    },
    "variant": "over exp",
    "createDate": "11/24/2018",
    "updateDate": "11/24/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15233,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, lung cancer cell lines and xenografts, overexpressing Fen1, were resistant to cisplatin treatment, as demonstrated by decreased apoptosis, reduced cells in G1 phase, and decreased tumor growth (PMID: 28371273).",
            "molecularProfile": {
                "id": 30880,
                "profileName": "FEN1 over exp"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12952,
                    "pubMedId": 28371273,
                    "title": "FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28371273"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15235,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, SC13, in combination with Taxol (paclitaxel), enhanced sensitivity of cervical cancer cell lines and xenografts, overexpressing Fen1, as demonstrated by increased apoptosis and decreased tumor volume (PMID: 29358095).",
            "molecularProfile": {
                "id": 30880,
                "profileName": "FEN1 over exp"
            },
            "therapy": {
                "id": 7519,
                "therapyName": "Paclitaxel + SC13",
                "synonyms": null
            },
            "indication": {
                "id": 4362,
                "name": "cervical cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12954,
                    "pubMedId": 29358095,
                    "title": "Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29358095"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15234,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, breast cancer cell lines and xenografts overexpressing Fen1 were sensitive to treatment with SC13, as demonstrated by decreased cell proliferation and tumor volume (PMID: 27852524).",
            "molecularProfile": {
                "id": 30880,
                "profileName": "FEN1 over exp"
            },
            "therapy": {
                "id": 7518,
                "therapyName": "SC13",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12953,
                    "pubMedId": 27852524,
                    "title": "Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27852524"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30880,
            "profileName": "FEN1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}